The effect of anti-glycophorin A monoclonal antibodies and FAB fragments on Plasmodium falciparum erythrocyte invasion in vitro by Roth, Stephen Joel
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
1986
The effect of anti-glycophorin A monoclonal
antibodies and FAB fragments on Plasmodium
falciparum erythrocyte invasion in vitro
Stephen Joel Roth
Yale University
Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Roth, Stephen Joel, "The effect of anti-glycophorin A monoclonal antibodies and FAB fragments on Plasmodium falciparum




Permission for photocopying or microfilming of 11 V • erf- - 
for the purpose of individual scholarly consultation or refer 
ence is hereby granted by the author. This permission is not 
to be interpreted as affecting publication of this work or 
otherwise placing it in the public domain, and the author re¬ 
serves all rights of ownership guaranteed under common law 
protection of unpublished manuscripts. 
Date 
Digitized by the Internet Archive 
in 2017 with funding from 




THE EFFECT OF ANTI-GLYCOPHORIN A MONOCLONAL ANTIBODIES 
AND FAB FRAGMENTS ON PLASMODIUM FALCIPARUM 
ERYTHROCYTE INVASION IN VITRO 
A Thesis Submitted to the Yale 
School of Medicine in Partial 
of the Requirements for the D 




Stephen Joel Roth 
1986 
M«*( ub 
'll i 3 








THE EFFECT OF ANTI-GLYCOPHORIN A MONOCLONAL ANTIBODIES 
AND FAB FRAGMENTS ON PLASMODIUM FALCIPARUM 
ERYTHROCYTE INVASION IN VITRO 
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1986 
Merozoites of the malaria parasite Plasmodium falciparum 
recognize and attach to erythrocyte sialoglycoproteins when 
invading human erythrocytes. On the major 
sialoglycoprotein, Glycophorin A (GpA), attachments appear 
to occur both to oligosaccharides on the NH2-terminal 
portion of the molecule and to a site close to the 
erythrocyte membrane. Three anti-GpA monoclonal antibodies, 
R7, RIO, and R18, and their Fab fragments were tested for 
the ability to inhibit P. falciparum erythrocyte invasion 
using in vitro invasion assays. Only R7, which is directed 
against a region of GpA near the membrane, produced strong 
inhibition both as an intact antibody and in Fab fragment 
form. GpA cross-linking and erythrocyte agglutination, two 
potential inhibitory mechanisms complicating the 
interpretation of the results with intact antibody, are 
ruled out by this result with R7 Fab fragments. The 
pattern and degree of inhibition caused by RIO and R18, 
which are directed against sites on GpA further from the 
membrane, suggest that they inhibit by a mechanism such as 
steric hindrance. The results of these studies provide 
additional evidence that a site on GpA close to the 

erythrocyte membrane is critical for P. falciparum invasion. 
Preliminary work with BRC14, an anti-GpA monoclonal antibody 
with the same serological specificity as R7, gave results 
similar to those observed with R7. 
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Malaria is a parasitic disease of both humans and a 
number of animal species which is caused by protozoa of the 
genus P1asmodium. Human malaria, targeted for global 
eradication by the World Health Organization as recently as 
the 1960s, has increased two- to three-fold in prevalence 
worldwide during the past 10-15 years (1). The reasons for 
this resurgence are complex and include a variety of 
biological, cultural, and economic factors (2). Of the four 
species of human malaria parasites, Plasmodium falciparum 
causes the majority of the morbidity and mortality 
associated with malarial disease. Because of this notorious 
preeminence and recent advances in iji vitro culturing 
techniques, efforts to develop new anti-malarial 
pharmacologic and immunologic agents have been focused 
primarily on P_j_ falciparum. 
Erythrocyte invasion by P^ falciparum is a complex, 
multi-step event which initiates the pathophysiologic 
processes that lead to disease in man. The invasive form of 
the parasite, the merozoite, must recognize and attach to an 
erythrocyte, orient its apical end towards the cell’s 
surface, form a movable junction with the cell’s membrane, 
and finally enter the cell by a specialized type of 
endocytosis without destroying it. 
Although the detailed mechanisms of erythrocyte 
invasion are still unknown, it appears that P_^ falciparum 
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merozoites recognize and attach to specific erythrocyte 
receptor molecules. These receptor molecules are the human 
erythrocyte sialoglycoproteins or glycophorins. Because 
erythrocyte invasion is critical for parasite survival in 
man, a better understanding of the merozoite-glycophorin 
interaction may lead to the development of new and effective 
methods for blocking merozoite invasion. This appraoch 
would complement current efforts to develop vaccines against 
the sporozoite form of the parasite. 
The first three sections of this thesis describe the P. 
falciparum life cycle, the details of merozoite invasion as 
observed through the light and electron microscope, and the 
experimental data which support the role of glycophorins as 
receptor molecules for P_^_ falciparum merozoites. The fourth 
and fifth sections provide the materials, methods, and 
results of a series of experiments performed to assess the 
ability of anti-glycophorin A monoclonal antibodies and 
their Fab fragments to inhibit P^_ falciparum invasion. In 
the final section, these experimental results are discussed 
and interpreted in the context of our current understanding 
of the erythrocyte invasion process. 
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THE PLASMODIUM FALCIPARUM LIFE CYCLE 
The P_^ fa 1 ciparum life cycle (3) consists of separate 
sexual and asexual cycles in two different host organisms, 
the Anopheles mosquito and man (Figure 1). The asexual 
cycle in man is initiated when an infected female Anopheles 
mosquito injects saliva harboring sporozoites into a human 
while attempting to obtain the blood needed to produce her 
eggs. Inside the human host, sporozoites attach to and then 
invade hepatocytes. Each sporozoite develops first into a 
form of the parasite called a trophozoite and later into a 
schizont. The schizont consists of thousands of nuclear 
masses (up to 30,000/hepatocyte) which derive from the 
mature trophozoite nucleus by asexual division. Each 
nuclear mass becomes a daughter parasite called a merozoite. 
The entire proliferative process lasts approximately one 
week, at which time the mature schizont within a hepatocyte 
ruptures and liberates its merozoites. 
As merozoites enter the bloodstream from the liver 
parenchyma, they rapidly attach to and invade erythrocytes. 
Invasion starts an intra-erythrocytic cycle of development 
in which the merozoite grows into a young trophozoite called 
a ring form and then progresses through the trophozoite 
stage until the schizont stage is reached again. In the 
erythrocyte only between 8 and 32 merozoites (the average 
number being 16) are produced per schizont. When the 
schizont is mature, it ruptures and releases its merozoites 

Figure t. The life cycle of Plasmodium falciparum. 
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into the circulation. Within one half hour these released 
merozoites invade erythrocytes and initiate a new 
intra-erythrocytic cycle. 
By an unknown mechanism, a subpopulation of invading 
merozoites enters a sexual cycle resulting in the formation 
of male and female gametocytes. If a female Anopheles 
ingests gametocytes during a blood meal, male and female 
gametes form and then join to make a zygote in the 
mosquito’s stomach cavity. The zygote develops there into a 
motile ookinete form which penetrates the stomach wall and 
grows into an oocyst. Several hundred to one thousand 
sporozoites develop in each oocyst. These are liberated 
when the mature oocyst bursts open one to three weeks after 
gametocyte ingestion. The released sporozoites are 
dispersed throughout the mosquito’s body. Those which come 
into contact with salivary gland tissue penetrate it 
and lodge in the acinal ducts. If the mosquito bites 
another human, it can inject sporozoites along with saliva 
into that person, thereby transmitting the parasite and 
possibly initiating a new infection. 
The asexual erythrocytic cycle of parasite development 
is associated with the chills, fever, sweats, and related 
fever symptoms which characterize an acute attack of 
malaria. These paroxysms occur when schizonts rupture and 
release both merozoites and antigenic proteins that are 
by-products of intra-erythrocytic parasite development (4). 
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The higher morbidity and mortality rates associated with 
acute attacks and complications (e.g. massive hemolysis, 
renal failure, and cerebral malaria) of P_^ fa 1ciparum versus 
the three other human malarias are due to at least two 
distinct properties of this species. First, P_^ falciparum 
merozoites can invade a broader spectrum of erythrocytes 
than the other species (i.e. not only reticulocytes) (5). 
This ability allows Pj_ falciparum to produce higher 
parasitemias (concentration of asexual parasites per unit 
volume of blood) and thus greater degrees of erythrocyte 
alteration and destruction. Second, falciparum causes 
infected erythrocytes to be sequestered in the 
microcirculation (6). Sequestration reduces contact with 
the spleen , a major site of parasite destruction, and 
places merozoites in regions of the vasculature where blood 
flow is reduced. This provides slower moving erythrocytes 
for merozoites to contact and attach to, and also leads to 
vaso-occlusion. 
Several targets for potentially useful interventions 
emerge from a basic understanding of the P^_ falciparum life 
cycle. Natural disease transmission would be abolished if 
gametocyte formation were blocked or if mosquitoes were 
prevented from harboring parasites or biting humans. In 
these situations either gametocytes would not be introduced 
into mosquitoes or sporozoites would not be introduced into 
man. Human infection would be prevented if sporozoites were 
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destroyed or their development within hepatocytes inhibited 
once introduced into the body. Human disease would either 
be prevented or eliminated if erythrocyte invasion were 
blocked. Merozoites and specific merozoite-erythrocyte 
interactions would thus be targets for interventions 
designed to reduce malarial disease. 
A MICROSCOPIC VIEW OF INVASION 
The physical events of erythrocyte invasion have been 
documented in light microscopic studies with fa 1ciparum 
(7) and both light and electron microscopic studies with the 
simian parasite P^ knowlesi (8-13). The observations of 
Dvorak e_t. a_l. (8) and Aikawa e_t. aj^. (9) led to the 
realization that invasion is a brief but complex process. 
For descriptive purposes the process has been divided into 
the following phases: 1) recognition and attachment, 2) 
junction formation, 3) erythrocyte membrane invagination, 
and 4) erythrocyte membrane closure and parasitophorous 
vacuole formation. These phases are represented 
schematically in Figure 2. Less than 30 seconds is required 
for completion of all four phases (8). 
Invasion begins as a host erythrocyte’s life ends with 
rupture of a mature schizont and release of its merozoites. 
Individual P_. knowlesi merozoites are ellipsoidal in shape 
and measure about 1.5 Mm by 2.0m® (10). The anterior or 
apical end is distinguished by a small protuberance and a 

A B C 
Figure 2. The four major phases of merozolte invasion into 
an erythrocyte (top) and a close-up view of a merozoite dur¬ 
ing phase three of Invasion (bottom). Compiled from the 
results of Dvorak et. al. (8) and Aikawa et. ah (9). (A) 
Recognition and inTTia! attachment of the merozoite to the 
erythrocyte. If the attachment does not occur via the api¬ 
cal end of the merozoite (B), reorientation occurs. (C) 
Junction formation and the beginning of invagination. (D) 
Erythrocyte membrane invagination. (E) Closure of the 
erythrocyte membrane and completion of parasitophorous 
vacuole formation. M, merozoite; RBC, erythrocyte; 




series of organelles including paired rhoptry bodies and 
micronemes and microspheres. A series of ducts extend 
from the rhoptries to the apical surface. The nucleus is 
situated near the posterior end of the merozoite. A uniform 
surface coat of ~20nm thickness covers the entire merozoite 
(12) and is comprised of T- or Y-shaped bristle-like 
structures oriented perpendicularly to the outer membrane 
(10). Free P_;_ know 1 es i and f a 1 c iparum merozoites are 
not cabable of locomotion, but they do exhibit bending and 
generalized contractile movements (7,8). Because of this 
lack of directed movment, the meeting of a merozoite and 
an erythrocyte appears to occur by chance. 
Extensions of the bristle-like structures on the 
merozoite surface permit long-distance (60nm or more) 
contact between a merozoite and erythrocyte (10). This 
long-distance attachment may be the earliest event in 
the recognition and attachment phase. If the merozoite’s 
apical end is oriented towards the erythrocyte, a closer 
attachment characterized by thicker bristles of 20nm length 
occurs immediately (Figure 2B) (10). If initial contact is 
not made at the apical end, the merozoite reorients itself 
while maintaining its long-distance attachment to the 
erythrocyte (Figure 2A) (10). In either instance the 
erythrocyte bends spasmodically for 5-10 seconds following 
merozoite attachment (7,8). 
The entry phase begins as the membranes of the two 

8 
cells at the apical end attachment site form a region of 
close apposition (~10nm separation) called the junction (9). 
The erythrocyte membrane quickly becomes depressed and 
thickened in this region (Figure 2, bottom). One or more 
vacuoles or channels may appear in the erythrocyte cytoplasm 
under the junction (9). Entry proceeds by a progressive 
invagination of the erythrocyte membrane (Figure 2C). The 
pocket which forms during invagination will become a 
membrane surrounding the merozoite called the 
parasitophorous vacuole. 
Invagination is accompanied by movement of the junction 
from the point of apical end attachment to the edges of the 
erythrocyte opening (9,11) (Figure 2C). Since electron 
micrographs always show junction regions at both edges of 
the erythrocyte opening, it appears that the junction 
completely encircles the merozoite while moving over it. 
The membrane surfaces between the moving junction and 
initial attachment site are not joined, indicating that the 
junction migrates over the merozoite circumferentially as 
would a ring (9). The merozoite surface coat is not 
observed inside the forming parasitophorous vacuole. When 
the merozoite is completely interiorzed, the junction comes 
together over the posterior end of the merozoite and closes 
like an iris diaphragm (9) (Figure 2D and E). This restores 
the defect in the erythrocyte generated by membrane 




In electron micrographs the forming paras itophorous 
vacuole appears to be a continuation of the erythrocyte 
membrane (9). However, freeze fracture studies (11,13) have 
shown that the inner layer of the vacuolar membrane has a 
markedly reduced density of intramembranous particles 
relative to the erythrocyte membrane, and biochemical 
studies (14) have demonstrated that two erythrocyte membrane 
enzymes, NADH oxidase and ATPase, are in the opposite 
orientation in the vacuole than would be expected from 
simple erythrocyte membrane invagination. While it appears 
that the parasitophorous vacuole originates from the 
erythrocyte membrane, it is possible that some of it may 
derive from the merozoite (11). 
Although the mechanism of merozoite entry is unknown, 
one of the more widely held hypotheses is that the apical 
end organelles secrete a substance into the erythrocyte 
during invasion which disrupts the membrane (12,15). This 
hypothesis is based upon the observation that the micronemes 
disappear and the rhoptries lose their electron-dense 
appearance during erythrocyte membrane invagination (12). 
The electron-dense rhoptry material appears to be largely 
proteinaceous (15), and may consist of a histidine-rich 
protein first identified in cytoplasmic granules of the duck 
parasite lophurae (16). Indirect autoradiographic 
evidence suggests this protein may be located in or near the 
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rhoptries of P_^ knowlesi (17). A similar histidine-rich 
protein in P_^ falciparum has also been described (18). 
While the histidine-rich protein may be a critical factor 
for entry, its function and importance in this process have 
not yet been established. 
The observation of longer (60nm) and shorter (20nm), 
thicker merozoite surface filaments in electron microscopic 
studies supports a mechanism involving two different 
attachments at the beginning of invasion (10). The 60nm 
filaments may facilitate long-distance attachment and the 
20nm filaments a separate, short-distance attachment. Since 
the merozoite surface appears to be covered by anionic 
glycoproteins (10), these attachments could take place 
between surface proteins and/or saccharides on the 
interacting cells. Because the merozoite probably needs to 
be affixed firmly in order to continue with junction 
formation and entry, it seems likely that some attachments 
are made to erythrocyte surface molecules associated 
with the cytoskeleton. Among the erythrocyte surface 
molecules meeting this criterion is glycophorin A, which has 
an indirect connection through its association with band 3 
protein (19) and possibly a direct connection to the 
cytoskeleton through band 4.1 (20,21). 
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ERYTHROCYTE DETERMINANTS IN Pj. FALCIPARUM INVASION 
Species Specificity and the Erythrocyte Receptor Hypothesis 
The earliest clues to the nature of the biochemical 
events of erythrocyte invasion came from experiments 
designed to determine the basis of Plasmodium host 
specificity. McGhee (22,23) was the first to hypothesize 
that differences of the outer surface of the erythrocyte 
membrane were responsible for restricting P1asmodiurn species 
to a limited number of hosts. McGhee based his hypothesis 
on the observation that P^ lophurae, an avian malaria which 
infects ducks and chickens, infected duck erythrocytes 
introduced into chicken embryos at a significantly greater 
rate than the more numerous chicken erythrocytes (22). 
Using P^_ knowles i. Butcher ejt. a_l. (24) showed that 
susceptibility to invasion iji vitro correlated only with 
properties of erythrocytes, and that merozoites bound only 
to erythrocytes from susceptible hosts (e.g. merozoites 
bound to monkey and human erythrocytes but not hamster, 
rabbit, or guinea pig erythrocytes). These results 
indicated that a receptor for merozoites was located on the 
erythrocyte membrane, and that specific interactions between 
the surfaces of the erythrocyte and merozoite were necessary 
for invasion to occur. 
After obtaining preliminary evidence indicating that 
the P_^ knowlesi receptor on human erythrocytes was not one 
of the sialoglycoproteins (SGP) (25), Miller e_t. aK (26) 
I 
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performed a comparative study with P_;_ know 1 es i and P. 
falciparum to determine the basic differences in the 
receptors for these two parasites. Their experiments were 
made possible by a new iji vitro culture technique for P. 
falciparum developed by Trager and Jensen (27). Because 
parasites could be cultured continuously, Miller’s group 
was able to add parasite-infected erythrocytes to cultures 
of test erythrocytes and determine how efficiently the 
released merozoites infected test cells. 
Miller’s group first compared susceptibility to 
invasion in human erythrocytes lacking different blood group 
antigens. They found that while P^_ fa 1ciparum invaded 
erythrocytes lacking the Duffy antigens [Fy(a-b-)] as 
efficiently as normal erythrocytes, it invaded erythrocytes 
totally lacking glycophorin A [En(a-) (28,29,30)] to a level 
only 39-47* of normal erythrocytes. [It should be noted 
that En(a-) erythrocytes also have increased glycosylation 
of band 3 protein (29) and lack the Wright b (Wrb) antigenic 
determinant.] Secondly, they observed that trypsin (1 
mg/ml) or neuraminidase (25 U/ml) treatment of normal 
erythrocytes significantly reduced their susceptibility to 
P. falciparum but not to P_^_ know 1 es i invasion. The opposite 
result was obtained with chymotrypsin-treated (0.1 mg/ml) 
normal erythrocytes. Miller’s group interpreted these 
results to mean that different proteins or glycoproteins 
were involved in the recognition of erythrocytes by the two 
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parasites. Knowing that trypsin removed portions of the SGP 
and neuraminidase removed sialic acid from the erythrocyte 
surface, they postulated that the SGP served as the P. 
f alciparum receptor. Since En(a-) erythrocytes were 
only partially resistant to invasion, they thought 
glycophorin A could not be the sole receptor molecule. 
The Human Erythrocyte Sialoglycoproteins 
Before presenting the results of experiments which were 
performed to assess more precisely the role of the SGP, the 
essential features of these molecules will be reviewed 
briefly. When normal erythrocyte membranes are dissolved in 
an excess of sodium dodecyl sulfate and then electrophoresed 
on a polyacrylamide gel (SDS-PAGE), at least seven bands 
representing sialic acid-rich glycoproteins can be 
visualized by periodic acid Schiff (PAS) staining (reviewed 
in 31). These bands are comprised of at least four distinct 
sialoglycoproteins. The bands have been given a variety of 
names by different investigators, but will be referred to 
here according to Furthmayr (32) as glycophorin A (a2 
and a, PAS-1 and PAS-2), glycophorin B (6a and 6 , PAS-3) and 
glycophorin C ( p and v * PAS-2 ' ). These are shown in 
schematic form in Figure 3. 
The major sialoglycoprotein, glycophorin A (GpA), is an 
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Figure 3. Glycophorlns A, B, and C in the human erythro¬ 
cyte membrane (top) and the structure of the two types 
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normal 0-linked oligosaccharides attached to the glyco 
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molecular weight (33) which probably exists in the membrane 
as a dimer (34) because of hydrophobic interactions at its 
intramembranous segment. Estimates of the number of 
copies/cell vary between 5 x 105 (35) and 2 x 106 (36). GpA 
has a tripartite structure consisting of a glycosylated, 
NH2-terminal segment of 64 amino acids, a hydrophobic 
segment of 32 nonpolar amino acids, and a relatively 
hydrophi11ic, COOH-terminal segment of 35 amino acids (see 
Figure 4). 
Approximately 60% of the dry weight of GpA is 
attributable to carbohydrate, all of which is located on the 
15 O-glycosidically linked tetrasaccharides and 1 
N-glycosidically linked oligosaccharide attached to the 
NH2~terminal segment (33). The structures of the two types 
of normal N-linked oligosaccharides (37) and three types of 
normal 0-linked tetrasaccharides (38) are shown in the 
bottom section of Figure 3. These oligosaccharides are not 
unique and can be found in other types of soluble 
glycoproteins. Each GpA monomer carries 32 sialic acid 
(N-acety1-neuraminic acid) moieties, giving both itself and 
the entire erythrocyte surface a net negative charge. 
When erythrocytes are treated with trypsin, GpA 
molecules are cleaved in their NH2~terminal segments. 
Two peptides named T1 and T2, both of which retain their 
attached oligosaccharides, are released (32). Trypsin 
treatment of purified GpA yields these same two 
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Figure 4. Amino acid sequence of human erythrocyte glycophorin A (top) 
and a schematic representation of the tryptic peptides of glycophorin A 
and their location relative to the erythrocyte membrane (bottom). 
Reprinted and redrawn from Tomita and Marchesi (33). CHO, oligosaccha¬ 
ride; O-glycosidic linkage;!^], N-glycosidic linkage. 
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glycopeptides plus several others (39,40). The amino acids 
(aa) comprising the six largest tryptic peptides of purified 
GpA are as follows: aa 1-39=T1, aa 1-31=T2, aa 40-61=T3, aa 
101 or 102-131=T4, aa 32-39=T5, and aa 62-97=T6 (40). The 
arrangement of these sequences on intact GpA is represented 
schematically in the bottom half of Figure 4. 
Several types of erythrocytes with alterations or 
deficiencies of GpA have been described. Homozygous En(a-) 
erythrocytes, which possess no detectable GpA, have already 
been discussed. AG erythrocytes have a hybrid glycophorin 
molecule consisting of approximately 56 aa of the 
NH2-terminal portion of GpA connected to the portion of 
glycophorin B inserted into the membrane (41). NH2~terminal 
portions of this hybrid glycophorin can be cleaved off by 
treatment with trypsin. MgMg erythrocytes have a single 
amino acid substitution of threonine -> asparagine at 
position 4 of the GpA sequence (42). This mutation prevents 
glycosylation at amino acids 2, 3, and 4 of GpA, so these 
cells are lacking three of the fifteen 0-linked 
oligosaccharides. McM erythrocytes have an amino acid 
substitution either at position 1 or 5 on GpA (42). Since 
the expression of M or N blood group activity depends on the 
nature of the amino acids at these two positions (39,43), 
McM erythrocytes are intermediate between normal M or N 
antigenic groups. 
Glycophorin B (GpB) is one of the minor erythrocyte 
■ 
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sialoglycoproteins and is not as well defined as GpA. It 
appears to be smaller than GpA, probably because it lacks a 
cytoplasmic segment (32). Erythrocytes are believed to 
possess approximately 70,000 copies of GpB/cell (32). 
Furthmayr (39) has shown that the first 23 to 25 
NH2-terminal amino acids of GpA (blood group N) and GpB are 
identical, including the sites of oligosaccharide 
attachment. GpB differs from GpA, however, in at least 
three ways: 1) it lacks GpA’s N-linked oligosaccharide 
attached to asparagine at position 26, 2) it has a sequence 
on the COOH-terminal side of this position which is markedly 
different than GpA (39), and 3) it is not cleaved during 
trypsin treatment of erythrocytes. 
GpB is known to carry at least three antigens, the S 
and s antigens and the U antigen (31). The U antigen has 
not been characterized and its location is unknown. S and s 
antigenic activity are related to the amino acids and 
attached oligosaccharides at positions 25-31 of GpB (44). 
Erythrocytes lacking these three antigens, called S-s-U(-), 
have been described (45). They either lack GpB completely 
or possess GpB molecules which are deficient in carbohydrate 
moieties essential for Ss antigenic activity (46). 
Glycophorin C (GpC) is the other minor 
sialoglycoprotein on erythrocytes. Unlike GpA and GpB, 
whose PAS-staining bands on SDS-PAGE represent monomers or 
dimers of a single type of sialoglycoprotein, GpC is 
' 
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comprised of two different sialoglycoproteins, (J and Y (31). 
Approximately 35,000 copies of GpC exist per erythrocyte 
(32), making it the least prevalent of the glycophorins. 
Although GpC appears to have an N-linked oligosaccharide 
(32) and 0-linked oligosaccharides similar to those found on 
GpA (31), its NH2~terminal amino acid sequence (specifically 
the 3 sialoglycoprotein) is completely different (47). GpC 
on normal erythrocytes is susceptible to cleavage by 
trypsin. The glycopeptide liberated is called DTI and 
represents aa 1-47 (47). Two individuals lacking the 
Gerbich (Ge) antigen plus 3 , Y * and a third minor 
sialoglycoprotein designated 3i have been described (48). 
Because some of the erythrocytes circulating in these Ge(-) 
individuals are e 11 iptocy t ic, Anstee e_t. a^. (48) have 
proposed that one or more of these sialoglycoproteins have a 
role in maintaining the shape of the erythrocyte. 
Two other variant erythrocytes which have alterations 
in both GpA and GpB have been described. XU erythrocytes 
possess decreased amounts of sialic acid (approximately 46% 
of normal) and galactose (49) partly because of an acquired 
defect in 3-3-D-galactosy1transferase (50). This defect 
exposes a cryptantigen on erythrocytes called the Tn 
antigen. Affected individuals have Tn antigen on as few as 
5% or as many as 90% of their erythrocytes (51). Cad 
erythrocytes have a normal sialic acid content but possess a 
pentasaccharide containing a N-acetyl-galatosamine added in 
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a 3(1-4) linkage to the galactose present in the normal 
O-linked tetrasaccharides of GpA and GpB (52). 
While the function of the SGP is still unknown, they 
are known to carry a variety of blood group antigens (M and 
N on GpA, N, S, s, U on GpB) and to serve as a binding site 
for myxoviruses (GpA) (53). One of the chief difficulties 
in assigning specific functions to these molecules is the 
fact that individuals whose erythrocytes lack GpA [En(a-)], 
GpB [S-s-U(-)], or GpA and GpB [homozygous Mk erythrocytes, 
(54)] are all hematologically normal (31). 
The Role of Glycophorins in P. falciparum Invasion 
The two experimental approaches most commonly used to 
study the role of glycophorins (Gps) in P^ falciparum 
invasion have been invasion-inhibition experiments and 
merozoite-binding studies. In invasion-inhibition 
experiments, exogenous substances or altered erythrocytes 
are introduced into parasite cultures and their effect on 
invasion determined by comparing the percentage of 
erythocytes invaded in test versus control cultures. All of 
the following materials have been used in 
invasion-inhibition and/or merozoite-binding studies: 
1) crude glycophorin preparations and purified 
Gps in solution 
2) liposomes carrying Gps and purified GpA 
3) glycopeptide and peptide fragments of GpA 
4) erythrocytes altered by enzymatic treatments or 
genetically-defined membrane defects 
5) naturally occurring and synthetic saccharides 
6) polyclonal and monoclonal antibodies against GpA 
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Weiss ej^. aj^. (55) were the first to evaluate the 
effect of soluble human SGP on P_^ falciparum invasion in 
vitro. They added purified GpA to cultures of synchonized, 
schizont-infected erythrocytes and assessed the ability of 
merozoites to invade uninfected erythrocytes. GpA had no 
inhibitory effect at <200 \}g/ml concentration, but did cause 
28% inhibition at 500 Mg/ml. The inhibition observed, 
presumably due to a competitive effect, was felt by these 
workers to be too minor to provide support for GpA as a 
receptor. 
Since the report of Weiss ejb. a_l. (55), five more sets 
of experiments with both mixed and purified glycophorins 
have been published (56-60). Concentrations varying from 
0.05-1.0 mg/ml were required to achieve 50% inhibition 
levels. Of the preparations tested, Gps and GpA alone were 
the most inhibitory. However, in the hands of Vanderberg 
et. al. (60), there was no difference between Gps and 
individual fractions of GpA, GpB, and GpC. Schulman et^. a 1 ♦ 
(59) documented the inhibitory specificity of the Gps 
fraction from their erythrocyte membrane preparations 
by showing that other fractions (e.g. the band 3 membrane 
fraction) produced no inhibition. 
Instead of using soluble Gps during the entire 
incubation period needed for schizont rupture and merozoite 
invasion, Perkins (61,62) incubated soluble Gps with 
isolated merozoites before adding them to uninfected 
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erythrocytes. Purified GpA caused 7955 inhibition at only 10 
pg/ml, while 100% inhibition was achieved with 50 pg/ral. 
GpB inhibited invasion ~90% at 200 g/ml. Perkins also 
showed free merozoites possess a saturable binding site for 
125I-glycophorins (mixture), providing the first direct 
evidence that merozoites could bind to their proposed 
erythrocyte receptors (62). 
Although the methods employed both to prepare 
glycophorin and to assess invasion inhibition varied in the 
aforementioned studies, all the authors concluded that Gps 
were likely to be at least a component of the erythrocyte 
receptor (56-62). Based on her results, Perkins (62) 
suggested that GpB could function as a receptor molecule 
(although not as effectively) in addition to GpA in normal 
erythrocytes. Vanderberg et♦ al♦ (60), who found that GpA, 
GpB, and GpC were equally good inhibitors, suggested that 
they could all serve as receptor molecules. 
A second technique used to study the inhibitory 
activity of human Gps was the introduction of Gps-containing 
liposomes into invasion assay systems (57,58,61). Perkins 
(61) prepared liposomes by separately adding the aqueous 
phase, interphase, and 1ipid/glycolipid phase of a 
chloroform:methanol extraction of erythrocyte membranes to 
liposomes. Of the three liposome preparations, only the one 
containing the aqueous phase material, where the majority of 
the GpA partitioned, caused significant inhibition. Breuer 
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et. al. (58) utilized egg lecithin liposomes to which either 
no proteins, Gps extracted as by Perkins (62), or a human 
erythrocyte band 3 fraction was added. They found that 
6 to 7 times less Gps was required to give 50% inhibition 
when they were added in liposomes instead of in soluble 
form. Liposomes with no protein or the band 3 fraction had 
no significant inhibitory effect. In addition to supporting 
the results obtained with soluble Gps, Breuer’s group felt 
their liposome data suggested that the environment 
surrounding the glycophorins could strongly influence 
invasion inhibition as well. 
Based on the assumption that the glycophorins were the 
merozoite receptors, several investigators attempted to 
determine which domains of these molecules were critical for 
invasion. These domain analyses were performed by 
determining the inhibitory effects of enzymatically-derived 
glycophorin peptides on invasion. All the tryptic peptides 
of GpA shown in Figure 4 plus DTI (aa 1-47) from GpC and 
several other incompletely characterized peptides have been 
used in these studies. 
Three groups investigated the role of carbohydrate-rich 
domains by using the tryptic glycopeptides Tl, T2, T1+T2, 
T5, and DTI in invasion-inhibition experiments (58,60,62). 
The carbohydrate-rich domains were believed to be critical 
for invasion based on the earlier experiments of Miller et. 
a1. (26) and studies to be described subsequently. The 
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results of these domain studies are shown in Table 1. None 
of these glycopeptides caused a significant degree of 
inhibition except for the T1 of Perkins (62), which caused 
76+11% inhibition at 100 pg/ml. 
It is difficult to compare the results of these groups 
because different methods for purifying the glycophorins and 
assessing invasion inhibition were used. Perkins' result 
with T1 could be due to the fact that her original Gps 
preparation was significantly more inhibitory than the one 
used by Vanderberg e_t. aj^. (60) or Breuer e_t. aj^. (58). 
Vanderberg, however, suggested that the unexpectedly low 
level of inhibition observed with these fragments by his and 
Breuer's group was related to the dissociation of 
NH2_terminal segments from hydrophobic segments of GpA. He 
based this idea on work done by Furthmayr (39), who showed 
that these glycopeptides had a three- to four-fold decrease 
in MN blood group serological activity per mole compared 
with intact GpA. Because the hydrophobic segment is 
missing, these fragments cannot form micelle-like structures 
in aqueous solution (63), a phenomenon which produces 
clustering of the NH2-terminal oligosaccharides and a 
superior target for anti-M and N antibodies. Thus, 
sialoglycopeptides may not present the preferred cluster of 
oligosaccharide units to the merozoite in order to serve 
effectively as competitive inhibitors. 
Perkins (62) and Breuer e_t. aj^. (58) also used 

Table 1. Inhibitory Effect of Human Erythrocyte Glycophorins and Glycophorin 









tion vs. Coi 
Breuer jet. _al. None (Control) 0 0 
(59) Gps 100 50-5 
200 84-6 
T1+T2 1200 17-7 
T5 700 0 
T6 200 70-4 
Vanderberg et. al. None (Control) 0 0 
(61) Gps 100 25-5 
200 50-7 
GpA 100 30-4 
GpC 100 27-5 
T1 1000 24-3 
T2 1000 15-4 
DTI 1000 8-3 
Perkins (63) None (Control) 0 0 
Gps 50 85-7 
100 100 
GpA 50 77-11 
100 100 
T1 100 76-11 
T2 100 13-5 
T3 200 25-6 
T4 200 0-2 
T5 200 52-13 
T6 100 67-4 
Percent inhibition represents 100% (control invasion rate) minus the invasion 




glycophorin peptides to assess the importance of 
carbohydrate-poor domains for invasion. Tryptic peptides 
T3, T4 , and T6 were used in these experiments (see Figure 
4). As shown in Table 1, only T6 appeared to possess 
significant inhibitory activity. Both Perkins and Breuer 
et. al. suggested that the hydrophobic segment of GpA could 
be a merozoite binding site. This interpretation is 
complicated by the fact that non-inhibitory, soluble 
proteins can be transformed into potent invasion inhibitors 
by derivitization with hydrophobic side groups (64). 
Thus, the hydrophobic nature of T6 and not a binding site 
for merozoites may have caused the inhibition observed. 
Experiments with human erythrocytes altered either by 
enzymatic treatment or genetically-defined membrane defects 
have provided strong evidence in support of a receptor role 
for the Gps. Trypsin (26,65,66,67), neuraminidase 
(26,61,67), and pronase (67) treatment of erythrocytes have 
all been shown to decrease invasion significantly. 
Chymotrypsin, reported to be without effect at 0.1 mg/ml by 
Miller et^. al^. (26), decreased susceptibility to invasion by 
>75% when used at concentrations of 1 and lOmg/ml (66). 
While these enzymes are known to modify glycophorins on the 
erythrocyte surface, their effects are insufficiently 
selective to provide specific information on the importance 
of particular glycophorin molecules or domains for invasion. 
When used to treat variant erythrocytes, however, these 
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enzymes have provided important clues about individual 
glycophorin species. 
Glycophorins A, B, and C have all been implicated as 
receptors from studies done with erythrocytes possessing 
genetically-defined and acquired membrane defects 
(26,66,68-72). Table 2 summarizes the results of 
invasion-inhibition studies performed with the eight types 
of variant erythrocytes described in the previous section. 
A ninth type of variant erythrocyte called Wright b negative 
[Wrb(-)] was also once thought to be highly resistant to 
invasion (69). These erythrocytes lack the Wrb antigen 
because of an undetermined alteration between amino acids 
62 and 72 of GpA (73). Follow-up studies (74-77) have 
demonstrated that Wrb(-) erythrocytes are invaded normally 
by P_^ falciparum in vitro, so this variant is not included 
in Table 2. 
Although Miller e_t. a_l. (26) were the first to publish 
results showing En(a-) erythrocytes are partially resistant 
to invasion, Pasvol e^. aJU (68) were the first to argue 
strongly that this reduced susceptibility supported Perkins’ 
(61) proposal that GpA was a merozoite receptor. Pasvol 
tested En(a-) erythrocytes from three different donors and 
found the mean percentages of invasion for these 
erythrocytes were 8 + 7%, 12 + 1%, and 48 ± 5% of normal 
En(a+) erythrocytes. He also demonstrated that P. 
falciparum could grow equally well in En(a-) and En(a+) 

















Invasion Inhibition Experiments Performed with Genetically- 
Acquired Variant Erythrocytes 
Description 
Susceptibility in 
Range of % Control 
Invasion Study 
Complete lack of GpA 39-46 26 
7-57a 69 
38 72 
Hybrid glycophorin with 
—56 aa of GpA at (^-terminal 
end and remainder GpB 
25-70 69 
Removes 39 aa at NH^-terminal 
end of GpA 
15-31(36-70)b 69 
Lacking 3 0-linked oligo¬ 
saccharides at positions 2-4 
on GpA 
Normal 72 
Single aa substitution making 
GpA intermediate between nor¬ 
mal M and N antigenic groups 
Normal 72 
Complete lack of GpB or possess 87 26 




Removes 39 aa and 47 aa from 5-7(37-39)b 70 
NH2-terminal ends of GpA and 
2-8(11-31)b 71 GpC, respectively 
7-9(5) 67 
Complete lack of SGP J3, ,3,, 
and V 
51-63 73 
Removes 39 aa at NHp-terminal 
end of GpA 
17-29(27-38)5 47 





Range of % Control 
Invasion_ Study 
Inadequate glycosylation of GpA 100 26 





on 0-linked oligosaccharides of 
GpA and GpB 
1-13 72 
aThree different erythrocyte sources were used. Two lacked only GpA and one lacked 
part of GpB as well. 
bNumbers in parentheses are the range of percent invasion rates in trypsin-treated 




cells, and that anti-Ena antibodies could greatly reduce 
invasion into En(a+) cells in a specific fashion. Facer 
(66) showed that En(a-) cells were partially resistant to 
invasion and also argued that this supported an important 
role for GpA in invasion. 
The results of invasion-inhibition experiments with 
S-s-U(-) and trypsin-treated normal S+s+U(+) erythrocytes 
suggest GpB may also function as a F\_ fa 1ciparum receptor 
molecule (66,69,70). S-s-U(-) erythrocytes have a partial 
resistance to invasion (Table 2). Pasvol et^. a^. (69) and 
Howard e_t^. aj^. (70) have suggested a role for GpB based on 
the observation that trypsin-treated S+s+U(+) erythrocytes 
are intermediate in susceptibility between the more 
susceptible S+s+U(+) cells and the less susceptible S-s-U(-) 
cells. While S+s+U(+) erythrocytes possess intact Gps, 
trypsin-treated S+s+U(+) cells have only intact GpB (i.e. 
trypsin cleaves both GpA and GpC) and trypsin-treated 
S-s-U(-) cells have no intact Gps. Structural data showing 
GpA and GpB share identical NH2-terminal sequences for 23 to 
25 aa (39) and invasion-inhibition experiment results 
showing En(a-) erythrocytes are still partially susceptible 
have been cited in support of GpB as well (69). 
Both Tn and Cad erythrocytes have been demonstrated to 
be significantly resistant to invasion (69,71) (Table 2). 
The normal susceptibility of the Tn erythrocytes studied by 
Miller ej^. ajl. (26) (Table 2) could have been due to the 
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fact that their Tn donor had a relatively low percentage of 
erythrocytes affected by this acquired glycosylation defect 
(71). When approximately 90% of the erythrocytes used in 
test cultures were affected, invasion rates were <10% of 
normal (69,71). Because both GpA and GpB are altered in Tn, 
Cad, and AG erythrocytes, it is not possible to infer a 
specific role for either glycophorin from these results. 
MgMg and McM erythrocytes, which both have minor 
carbohydrate changes at the NH2-terminal end of GpA, are 
normally invaded (Table 2). 
Pasvol e_t. a^. (72) recently demonstrated that 
erythrocytes lacking GpC [Ge(-)] are partially resistant to 
invasion (Table 2). Invasion of Ge(-) erythrocytes was 
approximately 57% of normal erythrocytes. Trypsin treatment 
of Ge(-) erythrocytes, like treatment of S-s-U(-) 
erythrocytes, reduced invasion further. Although the amino 
acid sequence of GpC is different from that of GpA and GpB, 
GpC’s oligosaccharides appear to be similar (47). While 
these results have been used to support a role for GpC in 
merozoite invasion (72), it should be remembered that at 
least some Ge(-) erythrocytes are elliptocytic and may have 
cytoskeletal alterations as well. 
Carbohydrates on the erythrocyte surface have been 
considered important to the erythrocyte-merozoite 
interaction ever since Miller et^. aj^. (26) first showed that 
neuraminidase treatment greatly reduced invasion. The 
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binding of P_^ fa 1ciparum to erythrocyte carbohydrates would 
not be an unusual mechanism of cell-cell interaction, since 
other parasites (78,79) and some viruses (80) and bacteria 
(81-83) bind to receptors comprised of carbohydrate 
molecules. In these interactions, which resemble the 
binding of plant lectins such as wheat germ agglutinin and 
soy bean agglutinin, carbohydrates appear to serve as 
bridging ligands. 
One of the most commonly employed methods for studying 
lectin-like binding phenomena is the use of exogenous 
saccharides in competitive inhibition experiments. The 
complex structure of the oligosaccharide side chains 
attached to GpA (Figure 3) has prompted the testing of more 
than 40 different saccharide species for their ability to 
inhibit invasion (55,56,58,60,62,70,84-86). Table 3 lists 
the 13 molecules which have been shown by investigators to 
cause >40% inhibition at <100mM in invasion assays with 
schizont-infected erythrocytes. Those molecules known to 
cause a toxic or reversibly retarding effect on developing 
parasites are excluded [e. g. glucosamine-HCL (55), fucose 
(55), and mannose (86)]. The inhibitory effect of 
N-acety1-D-glucosamine (GlcNAc) was originally felt to be 
secondary to a toxic effect (55). Jungery et. a1. (57), 
however, used both lower concentrations (<25mM) and GlcNAc 
linked to bovine serum albumin (BSA) to exclude toxicity and 
demonstrate a true inhibitory effect for this saccharide. 

Table 3. Saccharides Causing Significant Inhibition (>40%) of falciparum 
Invasion When Added as Exogenous Competitors 
Saccharide 
Range of concentrations 
tested (mM) 
Range of inhibition 
observed (% vs control) Stu< 
DGlcNAc 0.1-100 10-95 86 
2.5-30 6 to >95 87 
2.5-40 8-90 61 
2.5-80 10-100 58 
5-100 2-100 56 
10-100 0-100 71 
25 69 59 
NeuNAc 3.0 0 57 
10.0 17 59 
10-20 21-30 87 
2.5-25 0-52 58 
2.5-40 5-85 61 
DGalNAc 5-80 7-70 58 
10-100 0-90 71 
100 0 56 
Chitobiose 1-10 3-80 71 
2.5-30 52-85 87 
Not given Negative 59 
NeuNGc 2.5-40 10-95 61 

Table 3. (Continued) 
Saccharide 
Range of concentrations 
tested (mM) 
Range of inhibition 
observed (% vs control) Study 
NeuNAc-Lac 2.5-20 5-55 61 
oc DGlcNAcOMe 10-30 23-60 87 
aDGalNAcOMe 10 and 30 26-61 87 
Colomic Acid 0-2.0mg/ml 0-87 61 
£DGlcNAc(1>4)«DManOMe 10-20 66-81 87 
DGlcNAc, N-acetyl-D-glucosamine: NeuNAc, N-acetyl-neuraminic acid: DGalNAc, 
N-acetyl-D-galactosamine: Chitobiose, ^3DGlcNAc( 1>>4)DGlcNAc , NeuNGc, N-glyco- 
lylneuraminic acid: NeuNAc-Lac, N-acetyl neuramin-lactose: ©<DGlcNAcOMe, 




Subsequent studies with conjugated GlcNAc have supported 
these results (85,86). 
Of the 13 saccharides listed in Table 3, DGlcNAc has 
often produced the greatest degree of inhibition in 
comparative studies by different investigators. An 
inspection of the oligosaccharide structures found on GpA 
(Figure 3) reveals that GlcNAc is a common terminal and core 
saccharide moiety. Exogenous DGlcNAc may inhibit merozoites 
from binding to glycophorins by competing with the GlcNAc 
found in glycophorin oligosaccharides. The other inhibitory 
saccharides presumably generate a similar type of 
competitive inhibition, but it should be noted that not all 
of the saccharides found in Table 3 are represented on 
glycophorin oligosaccharides. Also, some of the saccharides 
present on glycophorin, such as galactose, do not inhibit 
invasion when added to cultures (55,57,86). Until the 
three-dimensional structures of the glycophorin 
oligosaccharides are known, it will be difficult to explain 
why saccharides such as galactose do not inhibit invasion. 
Both terminal (e.g. NeuNAc and GlcNAc) and core [e.g. 
PG lcNAc ( l-*4 ) DG lcNAc and PDG1 cNAc (l-»4 ) aDMan] saccharides 
appear to play a role, however. 
Conflicting results and differing invasion-inhibition 
assay methods have led to uncertainty in the literature 
concerning a role for sialic acid (N-acetyl-neuraminic acid, 
NeuNAc). Several groups showed that neuraminidase treatment 
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of erythrocytes significantly reduced invasion (26,61,70), 
but soluble, desialylated Gps did not appear to be less 
inhibitory than soluble, untreated Gps in most experiments 
(26,61,84). Earlier competitive inhibition experiments with 
NeuNAc suggested it was non-inhibitory (56,58,86) (Table 3), 
but Vanderberg ejt. a_l. (60) recently tested it over a wide 
range of concentrations and found the previous negative 
results to be attributable to insufficient amounts of NeuNAc 
added to cultures. Jungery ejt. a_l. (57) found similar 
results. Although one group has claimed sialic acid plays a 
very important role in invasion (60), all the groups 
investigating sialic acid state that it is not, by itself, 
sufficient for invasion. Several lines of evidence suggest 
that the negative charge imparted to the erythrocyte 
surface by sialic acid does not determine merozoite 
recognition (reviewed in 87). 
Competitive inhibiton experiments similar to those 
performed with free saccharides have also been performed 
with saccharides coupled to BSA (57,85,86). Jungery e_t. al. 
(57) coupled GlcNAc and lactose to BSA by a p-aminopheny1 
spacer to prevent these saccharides from entering 
erythrocytes and producing toxic effects on developing 
parasites. While BSA alone and BSA-lactose caused no 
invasion inhibition from 10_6M to 10_1M, BSA-GlcNAc produced 
strong inhibition up to 10-5M. Compared to GlcNAc alone, 
BSA-GlcNAc was approximately 100,000 times more effective 
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in producing inhibition. Schulman «?t_. a_K (85) prepared BSA 
conjugates of GlcNAc and several other saccharides with 
amide spacers and found BSA-GlcNAc was 84 times more 
effective than GlcNAc in producing identical levels of 
inhibition. 
Hermentin ejt. aj^. (86) were unable to generate a marked 
enhancement of inhibitory activity using a BSA-GlcNAc 
congugate prepared with an aliphatic spacer. Suspecting 
that the nature of the spacer might influence a congugate’s 
inhibitory ability, Hermentin’s group coupled BSA and GlcNAc 
with a variety of different spacers and showed that the 
strength of inhibition correlated closely with the degree of 
hydrophobicity of the spacer. Using amide spacers they 
found the greatest enhancement in inhibition with a 
BSA-pDGal (l-»3) aDGalNAc conjugate. This result suggests that 
the core structure of the 0-linked oligosaccharides plays 
a role in merozoite recognition and attachment. 
The ability of specific carbohydrates to inhibit 
invasion led to the idea that the interaction between 
merozoites and erythrocytes is lectin-like (57) and 
stimulated efforts to select for parasite proteins which 
bind to either GlcNAc (88) or Gps (88,89). Jungery e_t. al ♦ 
(88) added parasite proteins to a column of GlcNAc coupled 
to Sepharose 4B beads and found that three proteins of 
molecular weight (MW) 140 kilodaltons (kd), 70kd, and 35kd 
bound specifically to the coupled sugar. The 140kd and 35kd 
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proteins plus two others of 210kd and 140kd also bound to 
Gps coupled to Sepharose beads. Perkins (89) selected 
two different parasite proteins, one of 155kd and another of 
133kd, using Gps attached to acrylamide beads. The 
identification of these glycophorin binding proteins has led 
to the isolation of parasite genes (90) which may be useful 
for vaccine development. 
Another experimental approach used to study the role of 
Gps in falciparum invasion has been anti-Gps antibodies. 
Perkins (61) was the first to show that anti-Gps antibodies 
could inhibit invasion. She prepared a GpA-rich fraction 
from erythrocyte membranes, immunized rabbits with it, 
purified immunoglobulin G (IgG) from rabbit serum, and 
demonstrated that this antiserum agglutinated erythrocytes. 
In immunoprecipitation studies, this antiserum bound to GpA 
dimers, GpA monomers, and GpB, so it lacked specificity for 
GpA. Fab fragments of these polyclonal anti-Gps antibodies 
abolished the ability of soluble GpA to inhibit invasion. 
Merozoites pre-incubated with these Fab fragments at 1 mg/ml 
were also unable to invade erythrocytes. While these 
experiments established that anti-Gps antibodies could 
inhibit invasion, they did not provide any detailed 
information about the mechanism of invasion inhibition. 
Several of the limitations of the anti-Gps antibody 
approach encountered with polyclonal antibodies were 
overcome when a series of mouse anti-Gps monoclonal 
' 
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antibodies (mAb) produced by Anstee and Edwards (91) were 
used in invasion-inhibition experiments. The target sites 
of these mAb are depicted in Figure 5, and a brief 
description is given below. 
R1.3 recognizes a common NH2~terminal portion of GpA and 
GpB, and probably is targeted against saccharide moieties on 
t hem (91). 
RIO is directed against the trypsin-sensitive region of GpA, 
which is located beteween amino acids 30 and 40 from the 
NH2-terminal end (91). 
R7, BRC13, BRC14, and BRC15 all react with the Wrb antigen 
(91), an antigenic determinant which is located close to the 
membrane between amino acids 62 and 72 of GpA (73). 
R18 is directed against a portion of GpA below the 
trypsin-sensitive region, but not the portion where the Wrb 
determinant is located (91). 
Pasvol et. al. (69) were the first to study the 
inhibitory effects of mAb R7, BRC13 and 15, and R18. When 
added at subagglutinating concentrations to cultures 
containing normal, uninfected erythrocytes and 
schizont-infected erythrocytes, only R7, BRC13, and BRC15 
significantly inhibited invasion (54% to 100% inhibition was 
observed). Jungery (92) evaluated mAb RIO, R18, and R7 at 
subagglutinating concentrations and found R7 to be the only 
one capable of producing strong (78%) inhibition. She 
also tested a variety of combinations of these antibodies 
and mAb R6A, which is directed against a non-glycophorin 





Figure 5. Target sites of anti-glycophorin A monoclonal antibodies 
R1.3, R7, RIO, R18, and BRC14. R1.3 is directed against an epitope 




group antigens (Anstee, personal communication). R6A was 
non-inhibitory when added alone and did not appear to change 
the strong inhibitory effect of R7 or the non-inhibitory 
effect of RIO or R18 in combination with these mAb. 
Although R18 and RIO were not inhibitory by themselves, RIO 
plus R18 caused 50% inhibition. 
Three other investigators have reported results of 
invasion-inhibition assays with these mAb (77,87,93). Facer 
(93), who controlled for hemagglutination by using an 
erythrocyte monolayer on cover slips, found R7 to be a 
strong (95%) inhibitor and R1.3, R6A, RIO, and R18 all to be 
non-inhibitory. Schulman et. al. (77) found R7 to be 
non-inhibitory (<25% inhibition) at subagglutinating 
concentrations. R7 was, however, more inhibitory than RIO 
and R18 over the entire range of dilutions tested (1:20 to 
1:2560). One possible explanation for Schulman's results is 
that he added less mAb to cultures than the other 
investigators, but this cannot be determined since 
concentration data are available only from one of the 
studies. Pasvol (87) found that BRC14 was the most 
inhibitory of a group consisting of BRC14, R1.3, RIO, and 
R18. He observed minimal to moderate inhibition (30% to 
50%) with R10 at 80 Mg/ml and R18 at 70 pg/ml. Again, it is 
difficult to interpret these results in relation to other 
studies because of the lack of concentration data. Except 
for the result of Schulman et. al. (77) with R7, the results 

34 
from all of these studies suggest that a region on GpA close 
to the erythrocyte membrane is critical for P^_ falciparum 
invasion. 
The Two-Step Model of P. fa1ciparum Erythrocyte Invasion 
The experimental results reviewed in the previous 
section strongly support an important role for the 
glycophorin family of molecules in falciparum invasion 
and suggest that two different regions of the glycophorins 
are involved in merozoite recognition and attachment. 
Pasvol et. a1. (69) were the first to propose that the 
merozoite initially attaches to oligosaccharide molecules on 
glycophorins and then subsequently attaches to a site on 
these same molecules close to the erythrocyte membrane 
(the two-step model). The essential interactions 
encompassed in the two-step model can be summarized as 
follows (see Figure 6). A small group of lectin-like 
surface molecules on merozoites recognize and attach to 
specific clusters of oligosaccharides on the erythrocyte 
glycophorins. On GpA the O-linked tetrasaccharides attached 
to amino acids 10-15 and the single N-linked complex 
oligosaccharide appear to be more important than the 
tetrasaccharides on the first five NH2-terminal amino 
acids. Oligosaccharides on GpB and GpC also probably 
contribute, but to a lesser degree than GpA. Terminal 
saccharide moieties such as NeuNAc and GlcNAc participate in 

A 
Figure 6. Proposed model of the two-step recognition and attachment 
process. (A) Lectin-like proteins on the merozoite bind initially 
to oligosaccharide on the glycophorins. (B) The merozoite makes new 
attachments to sites close to the erythrocyte membrane on glyco- 
phorin A and/or B and C. RBC, erythrocyte; ■ , 0-linked oligo¬ 
saccharide; A , N-linked oligosaccharide; J Kandj“^/merozoite 
lectin-like proteins. inf Inf 
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binding, as do some core saccharide structures. Following 
this initial recognition and attachment stage, new 
attachments are formed to a region of the glycophorins near 
the membrane. This second attachment may serve to trigger 
the process of junction formation and erythrocyte 
deformation which lead to internalization of the parasite. 
The experiments which contribute the best evidence for 
a second attachment site are invasion-inhibition studies 
with anti-Gps mAb. There are a number of advantages to the 
use of mAb in studying parasite invasion. They include : 
1) mAb are targeted against specific epitopes; 2) the 
targets on proteins are typically less than 7 or 8 aa in 
size (94); 3) the potential exists to identify the parasite 
molecule(s) involved in invasion by making anti-idiotype 
antibodies to mAb. However, several potential complicating 
effects which make the interpretation of these results more 
difficult may occur when intact antibodies are added to 
erythrocytes. These potential complications include: 1) 
intact mAb are large (~150kd) relative to the glycophorins 
and may cause inhibition by steric hindrance; 2) bivalent 
antibody may cross-link Gps molecules and block binding 
sites or alter the deformabi1ity of the membrane (95); 3) 
mAb cause hemagglutination which might reduce invasion by 
decreasing the total surface area on erythrocytes available 
to merozoites. 
The primary goal of the experiments described in this 
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thesis was to eliminate or mitigate the potential 
complicating effects of intact mAb by performing 
invasion-inhibition assays with Fab fragments of R7, RIO, 
R18, and R6A. The possibility of invasion inhibition being 
produced by Gps cross-linking or hemagglutination will be 
eliminated with Fab fragments. Any inhibition secondary to 
steric hindrance should be reduced by the use of the smaller 
Fab fragments (~45kd versus ~150kd of intact IgG). Intact 
mAb were tested in this study to establish a baseline for 
comparison with the results of these Fab fragment 
experiments and studies published in the literature. All 
preparations of R7, RIO, R18, and R6A were quantified by 
radial immunodiffusion to aid in comparing results between 
different mAb and Fab fragments. Preliminary experiments 
with BRC14 mAb and Fab fragments were also performed, and 
these results are included as well. 
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MATERIALS AND METHODS 
Continous P_^ falciparum Culture 
A K+ clone of the Uganda-Palo Alto strain of P. 
falciparum was maintained in continuous iji vitro culture as 
described (27, 96). The medium used was complete RPMI [RPMI 
1640 (Gibco) supplemented with 3 g/L TES buffer, 2 g/L 
D-glucose, 2.3 g/L NaHC03, 40 mg/L gentamicin sulfate, 1.1 
mg/L pyruvic acid, and 30 mg/L L-glutamine] plus 10% type A+ 
or 0+ human serum. Erythrocytes were obtained from 0+Rh+ 
and A+Rh+ donors and stored at 4°C in a 1:10 dilution of 
citrate phosphate dextrose for a maximum of three weeks. 
Cultures were incubated at 37° C in 5% 02/5% CO2/90% N2. 
Synchronous cultures were obtained using 5% sorbitol as 
described (97). 
Monoclonal Antibodies 
The mAb used in this study were a gift of Dr. David 
Anstee, National Blood Transfusion Service, Bristol, 
England. All five mAb were raised against normal human 
erythrocytes and derived from mouse hybridomas. A thorough 
description of all except BRC14 has been published by 
Anstee and Edwards (91). 
Trypsin sites membrane 
(aj) U ( a2> Wrb 
RIO. 1 R18 R7 
BRCI4 




R6A was obtained from ascites. It is an IgGi mAb directed 
against a non-glycophorin protein on the erythrocyte 
membrane that may be linked to the Rhesus blood group 
antigens (Anstee, personal communication). 
RIO was obtained from ascites. It is an IgGi mAb directed 
against the trypsin-sensitive portion of GpA. 
R7 was obtained from ascites. It is an IgGi mAb directed 
against the Wrb determinant, which appears to be located 
between amino acids 62 and 72 of GpA (73). 
R18 was obtained from ascites. It is an IgG2b mAb directed 
against the portion of GpA remaining after trypsin 
treatment, but not the Wrb antigen. 
BRC14 was obtained from hybridoma culture supernatant. It 
is an IgGi mAb and has the same anti-Wrb specificity as R7 
(98) . 
Fab Fragment Preparation 
Purified mAb were prepared from ascites and hybridoma 
culture supernatant by sequential Na2SC>4 salt fractionation 
at 18%, 16%, and 16% followed by extensive dialysis against 
lOOmM PO4, 4mM EDTA, pH 7.5 (for papain digestion) or 
complete RPMI (for invasion assays). Protein concentration 
in these preparations was calculated from A280 measurements. 
Papain digestion was performed essentially as described 
(99). Briefly, cysteine to a final concentration of 5mM and 
2% by weight crystalline papain (Type IV, 2X crystallized, 
Sigma) were added to tubes containing purified mAb in 
PO4-EDTA buffer. After mixing, the tubes were flushed with 
N2, capped, and incubated in a 37°C water bath for 4 hours 
with intermittant mixing. The digestion was terminated by 




The completeness of papain cleavage was assessed by 
immunoblotting. Samples of each digest and the 
corresponding intact mAb were electrophoresed under 
non-reducing conditions on a 3-12% gradient 
SDS-polyacrylamide gel using the Laemmli buffer system 
(100). Gel proteins were electro-blotted onto 
nitrocellulose paper (NCP) (Scheicher and Schuell BA85 0.2m) 
as described (101). The NCP was incubated with a 1:100 
dilution of peroxidase-conjugated goat anti-mouse IgG 
F(ab)/2 antibody (Cooper Biomedical) for 2 hours. The NCP 
was developed using the immunoperoxidase technique as 
described (102). Two criteria were used to determine the 
extent of papain cleavage: 1) the presence of a band of 
45Kd MW corresponding to Fab fragment in digest sample lanes 
only, and 2) the absence of a band of ~150Kd MW 
corresponding to intact mAb in digest sample lanes which 
appeared in paired intact mAb lanes. 
Erythrocyte Binding Assay 
The five mAb used in this study are known to bind to 
and agglutinate normal human erythrocytes (91 and Anstee, 
personal communication). Erythrocyte binding was checked 
prior to invasion assays to confirm that binding ability was 
not lost during purification and Fab fragment preparation. 
Dilutions of each mAb or Fab fragment ranging from 1:100 to 
1:1600 were prepared in phosphate buffered saline (PBS). 
Identical dilutions of ascites obtained from mice injected 
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with SP2 cells, a variety of myeloma cells which do not 
secrete immunoglobulin, were used as a control. 75pl of 
each dilution was combined with 25 pi of pelleted, PBS-washed 
erythrocytes and the mixtures incubated at 37°C for 30 
minutes with gentle mixing every 5-10 minutes. The 
erythrocytes were then washed with 1 ml of PBS X 3 and 
incubated with 75 pi of a 1:10 dilution of 
fluorescin-conjugated rabbit anti-mouse IgG (Cooper 
Biomedical) at 37°C for 30 minutes. After washing with PBS 
as above, thin smears were prepared and stained with Giemsa. 
A largefield microscope (Leitz Orthroplan) with an 
epifluorescent condensor was used to view slides. Each 
smear was assessed both for the degree of erythrocyte 
agglutination and fluorescence. 
Radial Immunodiffusion Assays 
The concentration of immunoglobulin of the IgGi (R6A, 
R7, R10) and IgG2b (R18) subclasses and the concentration of 
Fab fragments were determined in undiluted samples using 
radial immunodiffusion as described (103, 104). The 
antisera employed were goat anti-mouse IgGi and IgG2t>, and 
the standards mouse IgGi and IgG2b (all from Meloy 
Laboratories). To convert the values obtained from mg/ml of 
immunoglobulin to M/L of mAb or Fab fragment, two 
assumptions were made. It was assumed that most of the 
immunoglobulin detected was mAb or Fab fragment, and 




The inhibitory effects of anti-glycophorin A mAb in 
unpurified, purified, and Fab fragment form were determined 
using invasion assays as described (68). Schizonts were 
obtained from synchronous cultures of P^_ falciparum using 3% 
gelatin (Plasmagel, Roger Bellon Laboratories, Neuilly, 
France)(105), and the yield of these cells determined from 
Giemsa-stained thin smears. Infected erythrocytes were 
combined with an appropriate volume of uninfected human 
erythrocytes so that 30 pi of this mixture provided a 1.5* 
hematocrit with 5* schizonts in a 200 pi culture. 30 pi of 
the erythrocyte mixture was added to duplicate micro tissue 
culture plate wells (Falcon, Micro Test III) containing 20 pi 
of human serum, 50 pi of complete RPMI, and 100 pi of 
unpurified or purified mAb diluted 1:12.5 to 1:800 in 
complete RPMI. Final dilutions varied from 1:25 to 1:1600. 
Cultures with Fab fragments also contained 30 pi of the 
erythrocyte mixture and 20 pi of human serum, but either 150 
pi of one Fab fragment type or 75 pi of each of two Fab 
fragment types were added undiluted to cultures. Control 
cultures contained identical volumes of the erythrocyte 
mixture and human serum plus either intact R6A mAb or Fab 
fragments as above, or complete RPMI in place of mAb. All 
mAb and Fab fragment preparations used in invasion assays 
were dialyzed previously against complete RPMI. Cultures 
were incubated overnight at 37°C in 5* 02/5* CO2/9O* N2. 
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Thin smears of each culture were made on microscope slides, 
stained with Giemsa, and viewed at 1000X under oil with a 
light microscope (Nikon Labophot). The invasion rate was 
calculated as the average percentage of ring forms present 
in two experiments with duplicate cultures based on counts 
of between 1000 and 2000 cells/culture pair. Invasion as a 
percentage of control was calculated by comparing the 
invasion rate of test cultures to the invasion rate of 
control cultures containing no mAb. The control culture 
invasion rate was set at 100% to allow for comparison 




The results of invasion assays performed with 
unpurified mAb from ascites and culture supernatant, 
purified mAb, and Fab fragments are given in Tables 4, 5, 
and 6. All of the intact mAb and Fab fragments used in 
invasion assays possessed the ability to bind to 
erythrocytes (data not shown). Both erythrocyte 
agglutination and a strong, generalized erythrocyte 
fluorescence pattern were observed at dilutions 1:100 
through 1:400 of intact mAb. Only a weaker, generalized 
fluorescence pattern was observed at higher dilutions of 
intact mAb. None of the Fab fragments caused erythrocyte 
agglutination at any dilution tested, but all of the Fab 
fragments produced generalized erythrocyte fluorescence at 
lower dilutions. None of the Fab fragment preparations used 
in invasion assays contained intact mAb detectable by 
immunoblotting (data not shown). 
Effect of Unpurified Monoclonal Antibody on Invasion 
Table 4 shows that R7 produced the strongest inhibition 
of the four unpurified anti-glycophorin A mAb tested. The 






to 95. 5% over a 
concentration range of 1.1 X 10'8 M to 1.7 x 10~ 7 M. 
Inhibition increased in a stepwise pattern with increasing 
concentration (Figure 7). RIO caused a moderate degree of 
inhibition ranging from 0% to 53.1% between 2.5 x 10-8M and 
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R7 in Ascites 
6a 
o 
Controls 11% 1:25 1:50 1:100 1:200 1:400 
No mAb 
Dilution of mAb 
No mAb 
Dilution of mAb 
Figure 7. Inhibition of P. falciparum invasion by monoclonal anti¬ 
body (mAb) R7 in ascites TTop) and purified R7 (bottom) over a di¬ 
lution range of 1:25 to 1:1600. Invasion rates (number of ring form 
parasites/100 erythrocytes in percent) in the absence of mAb were 11% 
and 7.7% for R7 in ascites and purified R7, respectively. 
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of RIO was about twice that at the same dilution of R7. 
Although less pronounced, an increasing pattern of 
inhibition similar to that observed with R7 was also noted 
for RIO. 
R18 and BRC14 both generated minimal inhibition which 
varied betweeen approximately 0% and 30% over the dilutions 
tested. R18 consistently caused less inhibition than R7 at 
the same concentrations. While R18 appeared to be less 
inhibitory than RIO over the entire dilutional range, R18 
produced a similar or greater degree of inhibition at three 
of four comparable concentrations (compare R18 1:50 to RIO 
1:100, R18 1:100 to R10 1:200, and R18 1:200 to R10 1:400). 
Since the concentration of BRC14 was not determined, no 
comparison between it and other unpurified mAb can be made. 
R6A caused an insignificant amount of inhibition which 
varied from 0% to 20% over concentrations ranging between 
1.3 x 10-8M to 2.0 x 10"7M. This degree of inhibition 
occurred despite hemagglutination at dilutions 1:25 and 
1:50. Less than 30% inhibition was also noted for dilution 
1:25 of R18 and dilutions 1:25, 1:50, and 1:100 of BRC14 in 
spite of hemagglutination. Greater than 85% inhibition was 
observed both in the presence (R7 1:25) and absence (R7 
1:50) of hemagglutination. 
Effect of Purified Monoclonal Antibody on Invasion 
Table 5 shows that R7 was the most inhibitory of the 
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invasion from 15.6% to 93.5% over a concentration range of 
I. 3 x 10”8M to 8.6 x 10“7M. A pattern of greater inhibition 
with greater concentration was noted here as with unpurified 
R7 (Figure 7). Assuming that there is a linear relationship 
between invasion inhibition and the concentration of R7 
present in culture, a surface binding curve can be plotted 
using least squares regression and a surface binding 
constant (Kd) estimated. Figure 8 shows a plot of the 
results for purified R7. Based upon the least squares 
fitted line described by the equation Y = (1.533 x 108)X + 
II. 967, the Kd of R7 can be estimated to be ~1 x 10_7M. 
Unlike RIO from ascites, purified RIO produced strong 
inhibition to a maximum of 85.1% at 5.1 x 10“7M. The degree 
of inhibition fell from 71.3% to only 12.7% with a change of 
dilution from 1:50 to 1:100, and all of the dilutions higher 
than 1:50 caused less than 15.2% inhibition. The abrupt 
loss of inhibitory ability did not correlate with a change 
in the hemagglutination pattern. At concentrations of 1.6 x 
10~8M or less, no inhibition was seen. 
R18 caused essentially the same degree of inhibition in 
purified form as it did in unpurified form. The percent 
inhibition was between 6.4% and 36.2% over a concentration 
range of 5.9 x 10"9M to 9.4 x 10_8M. Compared to R10 at 
slightly higher concentrations, R18 appeared to be more 
inhibitory (compare R18 1:25 to R10 1:100, R18 1:50 to R10 
1:200, and R18 1:100 to R10 1:400) although overall it again 
generated only minimal inhibition. 
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BRC14 was moderately inhibitory in purified form, 
causing between 0% and 55.5% inhibition from a 1:25 to a 
1:1600 dilution. A stepwise pattern of increasing 
inhibition with increasing antibody concentration as 
observed with both preparations of R7 was also observed 
here. Unpurified BRC14 did not produce this pattern. 
Effect of Fab Fragments on Invasion 
Table 6 and Figure 9 give the results of invasion 
assays performed with Fab fragments used either singly or 
combined in pairs at concentrations 10- to 100-fold greater 
than those of intact mAb. R7 Fab fragments caused 87.1% 
inhibition at 8.5 x 10~6M, which was the greatest amount of 
inhibition produced by any of the Fab fragments added 
singly. The moderate to marked inhibition observed with 
intact RIO was eliminated by papain cleavage, since only 
10.2% inhibition was seen with R10 Fab fragments at 7.5 x 
10_6M. R18 Fab fragments at 13 x 10_6M generated 43.4% 
inhibition, a value larger than any seen with intact R18. A 
moderate amount of inhibition, 48.3%, was observed with 
BRC14 Fab fragments. R6A Fab fragments produced an 
insignificant 5.5% inhibition at 12 x 10-6M. 
When the non-inhibitory R6A and R10 Fab fragments were 
combined at 6 x 10”6M and 3.7 x 10_6M, respectively, only 
7.8% inhibition was noted. R18 Fab fragments at 6.5 x 10-6M 
in combination with R6A or R10 Fab fragments generated 26.4% 
and 24.9% inhibition, respectively. The strong inhibitory 

Table 6. Results of Invasion Assays with Fab Fragments of R6A, R7, RIO, 
R18, and BRC14 Added Singly or in Combination 
Fab Fragments Concentration inM/La 
Percent . 
Inhibition D 
R6A 12x10“6 5.5 
RIO 7.5x10"6 10.2 
R18 13x10"6 43.4 
R7 8.5x10“6 87.1 
BRC14 n.d. 48.3 
R6A+R18 ★ 26.4 
R6A+R10 ★ 7.8 
R10+R18 ★ 24.9 
R7+BRC14 ★ 66.7 
R7+R18 ★ 90.9 
R10+R7 ★ 97.0 
aCalculated from radial immunodiffusion results as described in Materials 
and Methods 
^Percent inhibition represents the average value of inhibition rates deter¬ 
mined for experiments performed in duplicate. The inhibition rate is cal¬ 
culated as 100% (invasion rate in control cultures with no mAb set to 100%) 
minus the average test sample invasion rate. Average control invasion rate 
fo.r experiments with R6A, R7, and R18 was 11% and for experiments with RIO 
and BRC14 was 7.7%. 
n.d. not determined 
★ 
Concentrations of each Fab fragment used in combination experiments were 
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effect of R7 Fab fragments was preserved at 4.3 x 10_6M in 
combinations of R7+R18 and R7+R10 Fab fragments. Inhibition 
with the former combination was 90.9% and with the latter 
combination 97.0%. When R7 Fab fragments were added to 
BRC14 Fab fragments, which share R7*s anti-Wrb specificity, 




The experiments described here represent the first 
study of the inhibitory effects of Fab fragments of anti-GpA 
mAb R7, RIO, R18, and BRC14 on P_^ falciparum invasion in 
vitro. Invasion-inhibition experiments with intact R7, RIO, 
R18, and BRC14 were also performed to establish a basis for 
the comparison of results within this study and between this 
and previous studies. 
The stong inhibitory effect of intact mAb R7, whose 
target site is a segment of GpA near the erythrocyte 
membrane, supports the contention of other investigators 
(69,92,93) that this region of GpA is critical for merozoite 
invasion. Tables 4 and 5 show that R7’s greater inhibitory 
ability was not due to it being present in greater 
concentrations in test cultures. While there were no 
indications that R7 bound to erythrocytes better than the 
other mAb based on the dergee of hemagglutination or 
erythrocyte fluorescence in binding assays, it is possible 
that its surface concentration on erythrocytes was higher. 
R7*s estimated surface binding constant of ~1 x 10-7M 
suggests that it possesses good binding affinity for a mAb. 
The pattern of increasing inhibition with increasing 
concentrations of R7 suggests a linear relationship between 
invasion inhibition and mAb concentration (see Figure 7). 
R7 Fab fragments at a 10-fold greater concentration 
than purified, intact R7 generated — 90% inhibition (Table 
6), demonstrating that papain digestion did not destroy R7’s 
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strong inhibitory ability. Both hemagglutination and direct 
GpA cross-linking are eliminated as potential inhibitory 
mechanisms by this result. If intact R7 inhibits invasion 
by creating steric hindrance, then R7 Fab fragments appear 
to retain this ability. Steric hindrance should be reduced 
by the use of Fab fragments, however. The fact that R7 Fab 
fragments combined with either RIO or R18 Fab fragments also 
caused strong inhibition (Figure 9) supports the idea that 
R7*s effect dominated the effect of the other Fab fragments. 
However, in combination with Fab fragments of BRC14, which 
share R7’s anti-Wrb specificity and attach to a similar 
site on GpA, inhibition was reduced (Figure 9). Since BRC14 
Fab fragments appeared to be less inhibitory than R7 Fab 
fragments, this reduction might be the result of BRC14 
fragments binding to GpA and lowering the density of the 
more inhibitory R7 fragments. 
The minimal degree of inhibition (peak inhibition of 
35%, Tables 4 and 5) observed with intact mAb R18 suggests 
that it does not bind to a site on GpA which is critical 
for merozoite invasion. While intact, purified R18 did not 
cause strong inhibition at the same concentrations as R7 
(Table 5), there are indications that a concentration effect 
occurs with R18. As noted in the RESULTS section, intact 
R18 appeared to be at least as inhibitory as the moderately 
inhibitory RIO at similar concentrations. In addition, R18 
Fab fragments produced —50% inhibition at concentrations 
approximately 75- to 150-fold greater than the peak 
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concentrations of intact R18 tested. Finally, when R18 Fab 
fragments were combined at 6.5 x 10-6M (i.e. one half the 
concentration of R18 fragments added singly) with the 
non-inhibitory RIO or R6A fragments, inhibition was reduced 
(Figure 9). If greater concentrations of intact R18 had 
been added to cultures, a moderate degree of inhibition like 
that caused by RIO might have occurred. A concentration 
effect may explain the different degrees of inhibition 
reported for R18 in the literature (69,77,87,92,93). The 
target site for R18 on GpA is more distal than but still 
close to the target site for R7. The binding of intact R18 
or higher concentrations of R18 Fab fragments may partially 
block merozoites from binding to attachment sites closer to 
the erythrocyte membrane. 
The moderate to strong inhibition observed at peak 
concentrations of intact RIO was not seen with Fab fragments 
at 7.5 x 10_6M (Figure 9), suggesting that bivalent RIO 
molecules inhibit by a mechanism such as GpA cross-linking 
or steric hindrance. Because RIO binds to GpA in a region 
which is close to the oligosaccharides, it may hinder the 
initial attachment of merozoites to erythrocytes. RIO Fab 
fragments in combination with R6A or R7 Fab fragments did 
not alter the degree of inhibition seen when the latter 
fragments were added singly, suggesting that RIO was also 
non-inhibitory in these cultures. The relationship between 
percent inhibition and concentration of intact RIO does not 
appear to be linear (Table 5), a finding which suggests the 
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possiblity of interactions other than the simple attachment 
of RIO to its GpA target site (e.g. at higher 
concentrations, RIO might bind to itself and aggregate 
clusters of GpA molecules). 
Monoclonal antibody BRC14 was obtained from Dr. David 
Anstee near the end of these experiments, so this mAb was 
not as thoroughly studied. Although BRC14 appeared to be 
only minimally inhibitory when added in unpurified form 
(Table 4), it produced a moderate degree of inhibition in 
purified form (Table 5) and retained its inhibitory ability 
in Fab fragment form. BRC14 would be expected to inhibit 
invasion strongly based on its target region similarity with 
R7. BRC14*s lesser inhibitory ability could be due to a 
lower binding affinity, lower concentrations in culture, or 
a target region slightly removed from the merozoite 
attachment site. The difficulties encountered in 
interpreting the BRC14 results emphasize the importance 
of quantifying the amount of antibody used in 
invasion-inhibition experiments. 
Hemagglutination has been suggested as a possible 
inhibitory mechanism by two investigators (87,93). The 
control mAb in this study, R6A, produced insignificant 
inhibition despite causing hemagglutination at higher 
concentrations (Table 4). This observation demonstrates 
that hemagglutination alone does not necessarily cause 
inhibition. Since essentially normal invasion rates were 
observed in the presence of R6A (Table 4), inhibition 
- 
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also does not necessarily occur because the erythrocyte 
surface is covered with antibody. R6A did not produce 
significant inhibition in any of the studies where it was 
tested (77,87,92,93). 
Although these anti-GpA mAb studies are subject to 
fewer interpretational difficulties than previous studies 
using unquantified amounts of intact mAb, they nonetheless 
have several limitations. The chief constraint on this 
study was the limited quantity of mAb available. All of the 
mAb were a gift of Dr. David Anstee, and the original amount 
of each ascites or culture supernatant sample was 3.0 ml to 
4.5 ml. There was an insufficient quantity of mAb to 
perform experiments more than two times after preliminary 
studies on antibody binding, papain digestion conditions, 
and immunoglobulin purification methods were done. Since 
the mean values of the results of experiments with different 
antibody and Fab fragment preparations are represented by an 
N equalling 2, an analysis of statistical differences was 
not performed. 
In addition to the limitations imposed by the small 
amount of mAb available, time limitations did not allow me 
to perform two other control experiments. Although 
unlikely, some fraction of the inhibition observed with mAb 
could have been caused by toxic effects on intracellular 
parasite development. No reports of experiments to control 
for this possiblity appear in the literature. Toxic effects 
could be ruled out by adding varying concentrations of mAb 
1 
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and Fab fragments to synchronized cultures containing ring 
form parasites and monitoring development over a 40-48 hour 
period. Secondly, a control to eliminate the possibility 
that these mouse mAb bind to human immunoglobulins attached 
to the erythrocyte surface (e.g. the mAb might have 
anti-rheumatoid activity) would also have been useful. This 
experiment could be performed by attaching immunoglobulins 
from human serum to the inside of wells in a plastic dish, 
adding the mAb and Fab fragments to the wells, and 
determining if binding occurs. 
The surface binding curve shown in Figure 8 was drawn 
on the assumption of a linear relationship between percent 
inhibition and concentration of mAb. This assumption would 
be incorrect if bound mAb caused interactions between GpA 
molecules which led to phenomena such as aggregation. 
The assumption of a linear relationship between percent 
inhibition and antibody concentration does not depend on 
direct blockage of a merozoite binding site nor does it 
depend on a linear correlation between mAb binding and 
concent rat ion. 
An important limitation of this and all other iji vitro 
inhibition studies is that the intricacies of invasion occur 
in what largely remains a "black box". The light and 
electron microscope studies reviewed in the third section 
have revealed merozoite invasion to be a complex, multi-step 
process (7-11, 13). Invasion assays performed with 
synchronized, schizont-infected erythrocytes provide us only 
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with invasion rates at the endpoint of the process. While 
these rates suggest what interactions are taking place 
between the disappearance of schizonts and the appearance of 
ring forms, they provide no direct proof of mechanism. For 
example, inhibition produced by the addition of exogenous 
saccharides can be caused by inhibitory effects on parasite 
development as well as merozoite invasion (86). The 
creation of invasion assay systems using viable, isolated 
merozoites (62,107,108) represents the initial step in 
attempts to separate clearly inhibitory and toxic effects. 
Inhibitory mechanisms other than GpA cross-linking, 
hemagglutination, and steric hindrance may complicate the 
interpretation of invasion-inhibition experiments with mAb. 
Erythrocyte deformabi1ity appears to play a significant role 
in P_;_ falciparum invasion (109-111). Chasis et. al. (95) 
have shown that RIO and its Fab fragment may decrease 
membrane deformabi1ity by inducing an association between 
GpA and the cytoskeletal network. The results with RIO Fab 
fragments in this study do not suggest that a change in 
deformability affecting invasion occurred, but R7 could 
conceivably inhibit by this mechanism. The importance of 
hydrophobic interactions between merozoites and erythrocytes 
has also been demonstrated (58,62,64,86). By binding close 
to the membrane and to molecules of high density, R7 may 
prevent merozoites from attaching to the hydrophobic 
segments of other erythrocyte proteins important for 
invasion. The dramatic vacuolization which follows junction 
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formation must involve intimate contact between merozoite 
and erythrocyte membranes. After initial attachment occurs, 
intermembranous hydrophobic interactions could lead to 
junction formation and the inititation of parasite entry. 
Although many of the details of the P_^ falciparum 
invasion process are unknown, the identification of 
glycophorins as erythrocyte receptors has already led to 
progress in the search for a vaccine against merozoites. 
For an anti-malarial vaccine to be effective, it must 
inhibit some process critical for parasite survival and be 
targeted at molecules that vary minimally or not at all 
between members of a given species. Recognition of and 
attachment to erythrocytes are essential to parasite 
survival, since this activity allows for successive 
intra-erythrocytic cycles of parasite development. Also, it 
would be expected that the merozoite proteins responsible 
for binding to a specific erythrocyte molecule would not be 
highly variable. 
As mentioned earlier, Perkins (89) found two late-stage 
parasite proteins of 155kd and 133kd MW which appeared to 
have high affinity for Gps and represent glycophorin binding 
proteins (GBP). Antibodies to both effectively inhibited 
invasion, suggesting that these proteins did have an 
essential role in the erythrocyte-merozoite interaction. 
Based on these encouraging results, Ravetch et. al. (90) 
searched a cDNA library of late-schizont DNA for sequences 
whose expressed proteins reacted with antiserum raised 
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against the 155kd and 133kd proteins. Several clones 
were identified, and all shared a 150 nucleotide 
tandem-repeating sequence coding for a 50 amino acid repeat. 
The epitope represented by these repeat sequences thus 
appeared to be the target of the inhibitory antibodies 
against the GBP. 
The discovery of antibody-inducing epitopes comprised 
of tandemly repeated amino acid sequences on the surface 
proteins of merozoites [and also sporozoites (112)] should 
hasten the development of stage-specific vaccines consisting 
of these repeat proteins. A merozoite vaccine of this type 
would be expected to lead to immune responses capable of 
directly interfering with merozoite invasion in an infected 
host. 
During the discussion of the advantages of using mAb to 
study invasion mechanisms, it was pointed out that mAb can 
be utilized to generate anti-idiotype antibodies which might 
aid in the identification of merozoite proteins involved in 
erythrocyte invasion. Because R7 proved to be a strong 
inhibitor both as an intact antibody and as Fab fragments in 
this study, work is now in progress in the laboratory of Dr. 
Michele Jungery to raise and characterize anti-idiotype 
antibodies to R7. The results of these studies would be of 
potential usefulness for the development of stage-specific 
anti-merozoite vaccines and would contribute to a better 
understanding of the details of the invasion process. 
As promising as stage-specific vaccines appear on paper 
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and in controlled experiments, it should be remembered that 
the gap between an agent's efficacy in the laboratory and 
its effectiveness in the field may be enormous. In order to 
succeed in controlling an organism as adaptive as 
Plasmodium, an equal effort will have to be applied to the 
details of vaccine deployment. In many of the developing 
countries where a reduction in malaria morbidity and 
mortality would significantly improve the health of the 
population, no basic health care infrastructure now exists 
to implement an organized vaccination campaign. For this 
and other economic, social, and cultural reasons, malaria 
may continue to be a parasitic disease of worldwide 
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